Dagyagnao, Agnes B.

HRN: 17-95-25  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/02/2025
02/08/2025
IV
2.25gm
Q6
Sepsis
Waiting Final Action 
02/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/06/2025
02/12/2025
IV
4.5gm LD Then 2.25gm Q6H
Q6
Cap Mr
Rejected 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: